BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30043318)

  • 1. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
    Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
    Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study.
    Mehta RS; Lenzner D; Argiris A
    Ann Surg Oncol; 2012 Mar; 19(3):722-7. PubMed ID: 21947698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in racial disparities in pancreatic cancer surgery.
    Shah A; Chao KS; Ostbye T; Castleberry AW; Pietrobon R; Gloor B; Clary BM; White RR; Worni M
    J Gastrointest Surg; 2013 Nov; 17(11):1897-906. PubMed ID: 24002757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare disparities in outcomes of patients with resectable pancreatic cancer.
    Moaven O; Richman JS; Reddy S; Wang T; Heslin MJ; Contreras CM
    Am J Surg; 2019 Apr; 217(4):725-731. PubMed ID: 30583797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National failure to operate on early stage pancreatic cancer.
    Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS
    Ann Surg; 2007 Aug; 246(2):173-80. PubMed ID: 17667493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refusal of cancer-directed treatment by colon cancer patients: Risk factors and survival outcomes.
    Kaltenmeier C; Malik J; Yazdani H; Geller DA; Medich D; Zureikat A; Tohme S
    Am J Surg; 2020 Dec; 220(6):1605-1612. PubMed ID: 32680623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
    Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
    Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
    Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
    Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma.
    Coffman A; Torgeson A; Lloyd S
    Ann Surg Oncol; 2019 Jan; 26(1):98-108. PubMed ID: 30145650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in surgery for early-stage cancer: the impact of refusal.
    Rapp J; Tuminello S; Alpert N; Flores RM; Taioli E
    Cancer Causes Control; 2019 Dec; 30(12):1389-1397. PubMed ID: 31630307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refusal of surgery for colon cancer: Sociodemographic disparities and survival implications among US patients with resectable disease.
    Alty IG; Dee EC; Cusack JC; Blaszkowsky LS; Goldstone RN; Francone TD; Wo JY; Qadan M
    Am J Surg; 2021 Jan; 221(1):39-45. PubMed ID: 32723488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Lee DY; Teng A; Pedersen RC; Tavangari FR; Attaluri V; McLemore EC; Stern SL; Bilchik AJ; Goldfarb MR
    Ann Surg Oncol; 2017 Feb; 24(2):311-318. PubMed ID: 27766558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
    Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
    Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of stage I-III rectal cancer: Who is refusing surgery?
    Fields AC; Lu PW; Yoo J; Irani J; Goldberg JE; Bleday R; Melnitchouk N
    J Surg Oncol; 2020 May; 121(6):990-1000. PubMed ID: 32090341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
    Lu PW; Fields AC; Yoo J; Irani J; Goldberg JE; Bleday R; Melnitchouk N
    J Surg Oncol; 2020 Jun; 121(8):1306-1313. PubMed ID: 32227344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.